In the last 12 months, insiders at Emergent BioSolutions Inc. ($EBS) filed 155 transactions with the SEC: 1 open-market purchases totaling $349,800 and 16 sales totaling $1,837,107. Net insider sentiment: net selling.
Emergent BioSolutions Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Glessner Coleen (EVP, Quality & Ethics, and CPL) — 18 transactions totaling $915,352
- LINDAHL RICHARD S (EVP, Chief Financial Officer) — 21 transactions totaling $910,717
- PAPA JOSEPH C (President and CEO) — 8 transactions totaling $662,544
- DeGolyer Donald W (Director) — 7 transactions totaling $528,204
- Richard Ronald (Director) — 9 transactions totaling $521,590
View all SEC Filings for Emergent BioSolutions Inc. (EBS).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Williams Paul Anthony | SVP, Products Business | S | Common Stock | 4000 | $8.44 | 62,681.0000 | 56,700,000 | 6.00% | 0.01% |
| Feb. 25, 2026 | LINDAHL RICHARD S | EVP, Chief Financial Officer | H | Employee Stock Option (Right to buy) | 20321 | $0.00 | 0.0000 | 56,700,000 | 100.00% | 0.04% |
| May 7, 2025 | LINDAHL RICHARD S | EVP, Chief Financial Officer | H | Employee Stock Option (Right to buy) | 19963 | $0.00 | 0.0000 | 53,000,000 | 100.00% | 0.04% |
| March 3, 2026 | LINDAHL RICHARD S | EVP, Chief Financial Officer | A | Employee Stock Option (Right to buy) | 72856 | $0.00 | 557,346.0000 | 56,700,000 | 15.04% | 0.13% |
| March 5, 2026 | Glessner Coleen | EVP, Quality & Ethics, and CPL | F | Common Stock | 8199 | $8.44 | 104,108.0000 | 56,700,000 | 7.30% | 0.01% |
| March 3, 2026 | Glessner Coleen | EVP, Quality & Ethics, and CPL | A | Employee Stock Option (Right to buy) | 44834 | $0.00 | 294,447.0000 | 56,700,000 | 17.96% | 0.08% |
| March 3, 2026 | Perl Jessica | SVP, General Counsel, Corp Sec | A | Employee Stock Option (Right to buy) | 46702 | $0.00 | 142,647.0000 | 56,700,000 | 48.68% | 0.08% |
| March 3, 2026 | Williams Paul Anthony | SVP, Products Business | A | Employee Stock Option (Right to buy) | 44834 | $0.00 | 254,948.0000 | 56,700,000 | 21.34% | 0.08% |
| March 5, 2026 | LINDAHL RICHARD S | EVP, Chief Financial Officer | F | Common Stock | 23650 | $8.44 | 215,367.0000 | 56,700,000 | 9.89% | 0.04% |
| March 3, 2026 | Hartzel William | SVP, Bioservices | A | Employee Stock Option (Right to buy) | 44834 | $0.00 | 259,545.0000 | 56,700,000 | 20.88% | 0.08% |
| March 5, 2026 | Perl Jessica | SVP, General Counsel, Corp Sec | F | Common Stock | 6465 | $8.44 | 61,004.0000 | 56,700,000 | 9.58% | 0.01% |
| March 5, 2026 | Williams Paul Anthony | SVP, Products Business | F | Common Stock | 9397 | $8.44 | 66,681.0000 | 56,700,000 | 12.35% | 0.02% |
| March 5, 2026 | PAPA JOSEPH C | President and CEO | F | Common Stock | 37055 | $8.44 | 305,445.0000 | 56,700,000 | 10.82% | 0.07% |
| March 3, 2026 | PAPA JOSEPH C | President and CEO | A | Employee Stock Option (Right to buy) | 252194 | $0.00 | 1,784,694.0000 | 56,700,000 | 16.46% | 0.44% |
| March 3, 2026 | FOWLER JOHN D JR | Director | A | Common Stock | 5006 | $8.99 | 5,006.0000 | 56,700,000 | 9999.99% | 0.01% |
| March 5, 2026 | Lowry Simon C | SVP, R&D, CMO | F | Common Stock | 10636 | $8.44 | 77,803.0000 | 56,700,000 | 12.03% | 0.02% |
| March 3, 2026 | Lowry Simon C | SVP, R&D, CMO | A | Employee Stock Option (Right to buy) | 44834 | $0.00 | 147,833.0000 | 56,700,000 | 43.53% | 0.08% |
| March 5, 2026 | Hartzel William | SVP, Bioservices | F | Common Stock | 9493 | $8.44 | 87,188.0000 | 56,700,000 | 9.82% | 0.02% |
| March 1, 2026 | Glessner Coleen | EVP, Quality & Ethics, and CPL | F | Common Stock | 313 | $8.15 | 112,307.0000 | 56,700,000 | 0.28% | 0.00% |
| March 1, 2026 | LINDAHL RICHARD S | EVP, Chief Financial Officer | F | Common Stock | 683 | $8.15 | 239,017.0000 | 56,700,000 | 0.28% | 0.00% |
| March 1, 2026 | Williams Paul Anthony | SVP, Products Business | F | Common Stock | 116 | $8.15 | 76,078.0000 | 56,700,000 | 0.15% | 0.00% |
| Feb. 6, 2026 | Hartzel William | SVP, Bioservices | F | Common Stock | 630 | $10.92 | 96,681.0000 | 56,700,000 | 0.65% | 0.00% |
| Feb. 6, 2026 | Hartzel William | SVP, Bioservices | D | Common Stock | 5771 | $10.92 | 97,311.0000 | 56,700,000 | 5.60% | 0.01% |
| Feb. 6, 2026 | Williams Paul Anthony | SVP, Products Business | F | Common Stock | 1022 | $10.92 | 76,194.0000 | 56,700,000 | 1.32% | 0.00% |
| Feb. 6, 2026 | Williams Paul Anthony | SVP, Products Business | D | Common Stock | 8655 | $10.92 | 77,216.0000 | 56,700,000 | 10.08% | 0.02% |
| Feb. 6, 2026 | Glessner Coleen | EVP, Quality & Ethics, and CPL | F | Common Stock | 2852 | $10.92 | 112,620.0000 | 56,700,000 | 2.47% | 0.01% |
| Feb. 6, 2026 | Glessner Coleen | EVP, Quality & Ethics, and CPL | D | Common Stock | 28847 | $10.92 | 115,472.0000 | 56,700,000 | 19.99% | 0.05% |
| Feb. 9, 2026 | Perl Jessica | SVP, General Counsel, Corp Sec | F | Common Stock | 918 | $11.03 | 67,469.0000 | 56,700,000 | 1.34% | 0.00% |
| Feb. 6, 2026 | LINDAHL RICHARD S | EVP, Chief Financial Officer | F | Common Stock | 5642 | $10.92 | 239,700.0000 | 56,700,000 | 2.30% | 0.01% |
| Feb. 6, 2026 | LINDAHL RICHARD S | EVP, Chief Financial Officer | D | Common Stock | 46155 | $10.92 | 245,342.0000 | 56,700,000 | 15.83% | 0.08% |
| Dec. 14, 2025 | Lowry Simon C | SVP, R&D, CMO | F | Common Stock | 3543 | $11.41 | 88,439.0000 | 56,700,000 | 3.85% | 0.01% |
| Dec. 5, 2025 | Richard Ronald | Director | S | Common Stock | 14884 | $11.90 | 98,417.0000 | 56,700,000 | 13.14% | 0.03% |
| Dec. 5, 2025 | Richard Ronald | Director | M | Stock Option (Right to Buy) | 25748 | $0.00 | 0.0000 | 56,700,000 | 100.00% | 0.05% |
| Dec. 5, 2025 | Richard Ronald | Director | F | Common Stock | 10864 | $11.90 | 113,301.0000 | 56,700,000 | 8.75% | 0.02% |
| Dec. 5, 2025 | Richard Ronald | Director | S | Common Stock | 7100 | $12.11 | 98,417.0000 | 56,700,000 | 6.73% | 0.01% |
| Dec. 5, 2025 | Richard Ronald | Director | M | Common Stock | 25748 | $5.02 | 124,165.0000 | 56,700,000 | 26.16% | 0.05% |
| Nov. 11, 2025 | Hartzel William | SVP, Bioservices | F | Common Stock | 610 | $10.88 | 103,082.0000 | 56,700,000 | 0.59% | 0.00% |
| Nov. 10, 2025 | DeGolyer Donald W | Director | S | Common Stock | 17801 | $10.54 | 119,858.0000 | 56,700,000 | 12.93% | 0.03% |
| Nov. 7, 2025 | Dayal Sujata Tyagi | Director | S | Common Stock | 8552 | $10.00 | 88,980.0000 | 56,700,000 | 8.77% | 0.02% |
| Oct. 15, 2025 | LINDAHL RICHARD S | EVP, Chief Financial Officer | F | Common Stock | 4995 | $9.60 | 291,497.0000 | 56,700,000 | 1.68% | 0.01% |
| Oct. 7, 2025 | Glessner Coleen | EVP, Quality & Ethics, and CPL | S | Common Stock | 30608 | $10.00 | 144,319.0000 | 56,700,000 | 17.50% | 0.05% |
| Aug. 15, 2025 | Zoon Kathryn C | Director | S | Common Stock | 7086 | $8.87 | 71,799.0000 | 53,000,000 | 8.98% | 0.01% |
| Aug. 12, 2025 | DeGolyer Donald W | Director | S | Common Stock | 7844 | $8.65 | 137,659.0000 | 53,000,000 | 5.39% | 0.01% |
| July 11, 2025 | Hartzel William | SVP, Bioservices | F | Common Stock | 4263 | $7.36 | 103,692.0000 | 53,000,000 | 3.95% | 0.01% |
| June 8, 2025 | LINDAHL RICHARD S | EVP, Chief Financial Officer | F | Common Stock | 2733 | $6.63 | 296,492.0000 | 53,000,000 | 0.91% | 0.01% |
| June 8, 2025 | Glessner Coleen | EVP, Quality & Ethics, and CPL | F | Common Stock | 1249 | $6.63 | 174,927.0000 | 53,000,000 | 0.71% | 0.00% |
| June 8, 2025 | Hartzel William | SVP, Bioservices | F | Common Stock | 1167 | $6.63 | 107,955.0000 | 53,000,000 | 1.07% | 0.00% |
| June 8, 2025 | Williams Paul Anthony | SVP, Products Business | F | Common Stock | 464 | $6.63 | 85,871.0000 | 53,000,000 | 0.54% | 0.00% |
| May 23, 2025 | Katkin Keith | Director | S | Common Stock | 7844 | $6.30 | 86,431.0000 | 53,000,000 | 8.32% | 0.01% |
| May 13, 2025 | PAPA JOSEPH C | President and CEO | P | Common Stock | 60000 | $5.83 | 342,500.0000 | 53,000,000 | 21.24% | 0.11% |
| April 30, 2025 | DeGolyer Donald W | Director | A | Stock Option (Right to Buy) | 15824 | $0.00 | 41,572.0000 | 53,000,000 | 61.46% | 0.03% |
| April 30, 2025 | Richard Ronald | Director | A | Common Stock | 34403 | $0.00 | 105,517.0000 | 53,000,000 | 48.38% | 0.06% |
| April 30, 2025 | Richard Ronald | Director | A | Stock Option (Right to Buy) | 15824 | $0.00 | 41,572.0000 | 53,000,000 | 61.46% | 0.03% |
| April 30, 2025 | White Marvin L | Director | A | Common Stock | 34403 | $0.00 | 88,495.0000 | 53,000,000 | 63.60% | 0.06% |
| April 30, 2025 | White Marvin L | Director | A | Stock Option (Right to Buy) | 15824 | $0.00 | 41,572.0000 | 53,000,000 | 61.46% | 0.03% |
| April 30, 2025 | Fowler Neal Franklin | Director | A | Common Stock | 34403 | $0.00 | 135,503.0000 | 53,000,000 | 34.03% | 0.06% |
| April 30, 2025 | Fowler Neal Franklin | Director | A | Stock Option (Right to Buy) | 15824 | $0.00 | 41,572.0000 | 53,000,000 | 61.46% | 0.03% |
| April 30, 2025 | Zoon Kathryn C | Director | A | Common Stock | 34403 | $0.00 | 78,885.0000 | 53,000,000 | 77.34% | 0.06% |
| April 30, 2025 | Zoon Kathryn C | Director | A | Stock Option (Right to Buy) | 15824 | $0.00 | 41,572.0000 | 53,000,000 | 61.46% | 0.03% |
| April 30, 2025 | Dayal Sujata Tyagi | Director | A | Common Stock | 34403 | $0.00 | 97,532.0000 | 53,000,000 | 54.50% | 0.06% |
| April 30, 2025 | Dayal Sujata Tyagi | Director | A | Stock Option (Right to Buy) | 15824 | $0.00 | 41,572.0000 | 53,000,000 | 61.46% | 0.03% |
| April 30, 2025 | Katkin Keith | Director | A | Common Stock | 34403 | $0.00 | 94,275.0000 | 53,000,000 | 57.46% | 0.06% |
| April 30, 2025 | Katkin Keith | Director | A | Stock Option (Right to Buy) | 15824 | $0.00 | 41,572.0000 | 53,000,000 | 61.46% | 0.03% |
| April 30, 2025 | Harsanyi Zsolt | Chairman | A | Common Stock | 34403 | $0.00 | 123,732.0000 | 53,000,000 | 38.51% | 0.06% |
| April 30, 2025 | Harsanyi Zsolt | Chairman | A | Stock Option (Right to Buy) | 15824 | $0.00 | 41,572.0000 | 53,000,000 | 61.46% | 0.03% |
| April 30, 2025 | DeGolyer Donald W | Director | A | Common Stock | 34403 | $0.00 | 145,503.0000 | 53,000,000 | 30.97% | 0.06% |
| April 30, 2025 | SULLIVAN LOUIS W | Director | A | Common Stock | 34403 | $0.00 | 139,098.0000 | 53,000,000 | 32.86% | 0.06% |
| April 30, 2025 | SULLIVAN LOUIS W | Director | A | Stock Option (Right to Buy) | 15824 | $0.00 | 41,572.0000 | 53,000,000 | 61.46% | 0.03% |
| March 6, 2025 | Hartzel William | SVP, Bioservices | A | Common Stock | 62500 | $0.00 | 109,683.0000 | 53,000,000 | 132.46% | 0.12% |
| April 7, 2025 | Glessner Coleen | EVP, Quality & Ethics, and CPL | F | Common Stock | 480 | $4.44 | 176,176.0000 | 53,000,000 | 0.27% | 0.00% |
| April 7, 2025 | Hartzel William | SVP, Bioservices | F | Common Stock | 561 | $4.44 | 109,122.0000 | 53,000,000 | 0.51% | 0.00% |
| March 12, 2025 | Fowler Neal Franklin | Director | S | Common Stock | 35000 | $5.83 | 101,100.0000 | 53,000,000 | 25.72% | 0.07% |
| March 12, 2025 | Zoon Kathryn C | Director | S | Common Stock | 10000 | $5.73 | 44,482.0000 | 53,000,000 | 18.35% | 0.02% |
| March 12, 2025 | PAPA JOSEPH C | President and CEO | A | Employee Stock Options (Right to Buy) | 250000 | $0.00 | 1,532,500.0000 | 53,000,000 | 19.49% | 0.47% |
| March 12, 2025 | PAPA JOSEPH C | President and CEO | A | Employee Stock Options (Right to Buy) | 250000 | $0.00 | 1,282,500.0000 | 53,000,000 | 24.21% | 0.47% |
| March 6, 2025 | LINDAHL RICHARD S | EVP, Chief Financial Officer | A | Common Stock | 146888 | $0.00 | 299,225.0000 | 53,000,000 | 96.42% | 0.28% |
| March 6, 2025 | Hartzel William | SVP, Bioservices | A | Employee Stock Options (Right to Buy) | 62500 | $0.00 | 214,711.0000 | 53,000,000 | 41.06% | 0.12% |
| March 6, 2025 | Hartzel William | SVP, Bioservices | A | Common Stock | 62500 | $0.00 | 109,975.0000 | 53,000,000 | 131.65% | 0.12% |
| March 6, 2025 | Perl Jessica | SVP, General Counsel, Corp Sec | A | Common Stock | 62500 | $0.00 | 68,387.0000 | 53,000,000 | 1061.66% | 0.12% |
| March 6, 2025 | Perl Jessica | SVP, General Counsel, Corp Sec | A | Employee Stock Options (Right to Buy) | 62500 | $0.00 | 95,945.0000 | 53,000,000 | 186.87% | 0.12% |
| March 6, 2025 | Williams Paul Anthony | SVP, Products Business | A | Common Stock | 62500 | $0.00 | 86,335.0000 | 53,000,000 | 262.22% | 0.12% |
| March 6, 2025 | Williams Paul Anthony | SVP, Products Business | A | Employee Stock Options (Right to Buy) | 62500 | $0.00 | 210,114.0000 | 53,000,000 | 42.34% | 0.12% |
| March 6, 2025 | LINDAHL RICHARD S | EVP, Chief Financial Officer | A | Employee Stock Options (Right to Buy) | 178546 | $0.00 | 484,490.0000 | 53,000,000 | 58.36% | 0.34% |
| March 6, 2025 | Lowry Simon C | SVP, R&D, CMO | A | Common Stock | 62500 | $0.00 | 91,982.0000 | 53,000,000 | 211.99% | 0.12% |
| March 6, 2025 | Lowry Simon C | SVP, R&D, CMO | A | Employee Stock Options (Right to Buy) | 62500 | $0.00 | 102,999.0000 | 53,000,000 | 154.32% | 0.12% |
| March 6, 2025 | PAPA JOSEPH C | President and CEO | A | Common Stock | 282500 | $0.00 | 282,500.0000 | 53,000,000 | 9999.99% | 0.53% |
| March 6, 2025 | PAPA JOSEPH C | President and CEO | A | Employee Stock Options (Right to Buy) | 282500 | $0.00 | 1,032,500.0000 | 53,000,000 | 37.67% | 0.53% |
| March 6, 2025 | Glessner Coleen | EVP, Quality & Ethics, and CPL | A | Common Stock | 62500 | $0.00 | 176,656.0000 | 53,000,000 | 54.75% | 0.12% |
| March 6, 2025 | Glessner Coleen | EVP, Quality & Ethics, and CPL | A | Employee Stock Options (Right to Buy) | 62500 | $0.00 | 249,613.0000 | 53,000,000 | 33.40% | 0.12% |
| March 5, 2025 | Hartzel William | SVP, Bioservices | F | Common Stock | 292 | $5.80 | 47,183.0000 | 53,000,000 | 0.62% | 0.00% |
| Feb. 12, 2025 | Glessner Coleen | EVP, Quality & Ethics, and CPL | D | Common Stock | 24078 | $0.00 | 114,469.0000 | 53,000,000 | 17.38% | 0.05% |
| Feb. 12, 2025 | Glessner Coleen | EVP, Quality & Ethics, and CPL | D | Common Stock | 5913 | $0.00 | 138,547.0000 | 53,000,000 | 4.09% | 0.01% |
| March 1, 2025 | Glessner Coleen | EVP, Quality & Ethics, and CPL | F | Common Stock | 313 | $7.48 | 114,156.0000 | 53,000,000 | 0.27% | 0.00% |
| March 1, 2025 | LINDAHL RICHARD S | EVP, Chief Financial Officer | F | Common Stock | 683 | $7.48 | 152,337.0000 | 53,000,000 | 0.45% | 0.00% |
| Feb. 28, 2025 | LINDAHL RICHARD S | EVP, Chief Financial Officer | F | Common Stock | 1073 | $7.48 | 153,020.0000 | 53,000,000 | 0.70% | 0.00% |
| Feb. 12, 2025 | LINDAHL RICHARD S | EVP, Chief Financial Officer | D | Common Stock | 16916 | $0.00 | 154,093.0000 | 53,000,000 | 9.89% | 0.03% |
| March 1, 2025 | Williams Paul Anthony | SVP, Products Business | F | Common Stock | 116 | $7.48 | 23,835.0000 | 53,000,000 | 0.48% | 0.00% |
| Feb. 28, 2025 | Williams Paul Anthony | SVP, Products Business | F | Common Stock | 382 | $7.48 | 23,951.0000 | 53,000,000 | 1.57% | 0.00% |
| Feb. 9, 2025 | Perl Jessica | SVP, General Counsel, Corp Sec | F | Common Stock | 918 | $10.00 | 5,887.0000 | 53,000,000 | 13.49% | 0.00% |
| Dec. 15, 2024 | Lowry Simon C | SVP, R&D, CMO | A | Common Stock | 29482 | $0.00 | 29,482.0000 | 55,600,000 | 9999.99% | 0.05% |
| Dec. 15, 2024 | Lowry Simon C | SVP, R&D, CMO | A | Employee Stock Option (Right to buy) | 40499 | $0.00 | 40,499.0000 | 55,600,000 | 9999.99% | 0.07% |
| Dec. 8, 2024 | Glessner Coleen | EVP, Quality & Ethics, and CPL | F | Common Stock | 18674 | $9.01 | 144,460.0000 | 55,600,000 | 11.45% | 0.03% |
| Nov. 12, 2024 | DeGolyer Donald W | Director | S | Common Stock | 25000 | $10.91 | 111,100.0000 | 55,600,000 | 18.37% | 0.04% |
| Nov. 11, 2024 | Hartzel William | SVP, Bioservices | F | Common Stock | 632 | $11.97 | 47,475.0000 | 55,600,000 | 1.31% | 0.00% |
| Nov. 11, 2024 | White Marvin L | Director | S | Common Stock | 14287 | $11.97 | 54,092.0000 | 55,600,000 | 20.89% | 0.03% |
| Oct. 15, 2024 | LINDAHL RICHARD S | EVP, Chief Financial Officer | A | Common Stock | 15000 | $0.00 | 171,009.0000 | 55,600,000 | 9.61% | 0.03% |
| July 11, 2024 | Hartzel William | SVP, Bioservices | A | Common Stock | 15000 | $0.00 | 48,107.0000 | 51,200,000 | 45.31% | 0.03% |
| July 11, 2024 | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | A | Common Stock | 15000 | $0.00 | 186,382.0000 | 51,200,000 | 8.75% | 0.03% |
| July 8, 2024 | Williams Paul Anthony | SVP, Products Business | F | Common Stock | 85 | $8.13 | 24,333.0000 | 51,200,000 | 0.35% | 0.00% |
| June 8, 2024 | Glessner Coleen | EVP, Quality & Ethics, and CPL | F | Common Stock | 1249 | $6.19 | 163,134.0000 | 51,200,000 | 0.76% | 0.00% |
| June 8, 2024 | LINDAHL RICHARD S | EVP, Chief Financial Officer | F | Common Stock | 2733 | $6.19 | 156,009.0000 | 51,200,000 | 1.72% | 0.01% |
| June 8, 2024 | Williams Paul Anthony | SVP, Products Business | F | Common Stock | 464 | $6.19 | 24,418.0000 | 51,200,000 | 1.86% | 0.00% |
| June 8, 2024 | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | F | Common Stock | 2376 | $6.19 | 171,382.0000 | 51,200,000 | 1.37% | 0.00% |
| June 8, 2024 | Hartzel William | SVP, Bioservices | F | Common Stock | 1167 | $6.19 | 33,107.0000 | 51,200,000 | 3.40% | 0.00% |
| June 4, 2024 | Zoon Kathryn C | Director | S | Common Stock | 10000 | $6.11 | 54,482.0000 | 51,200,000 | 15.51% | 0.02% |
| May 29, 2024 | Zoon Kathryn C | Director | S | Common Stock | 1830 | $4.61 | 64,482.0000 | 51,200,000 | 2.76% | 0.00% |
| May 23, 2024 | Zoon Kathryn C | Director | A | Stock Option (Right to Buy) | 25748 | $0.00 | 25,748.0000 | 51,200,000 | 9999.99% | 0.05% |
| May 23, 2024 | Katkin Keith | Director | A | Common Stock | 17430 | $0.00 | 59,872.0000 | 51,200,000 | 41.07% | 0.03% |
| May 23, 2024 | Katkin Keith | Director | A | Stock Option (Right to Buy) | 25748 | $0.00 | 25,748.0000 | 51,200,000 | 9999.99% | 0.05% |
| May 23, 2024 | Fowler Neal Franklin | Director | A | Common Stock | 17430 | $0.00 | 136,100.0000 | 51,200,000 | 14.69% | 0.03% |
| May 23, 2024 | Fowler Neal Franklin | Director | A | Stock Option (Right to Buy) | 25748 | $0.00 | 25,748.0000 | 51,200,000 | 9999.99% | 0.05% |
| May 23, 2024 | DeGolyer Donald W | Director | A | Common Stock | 17430 | $0.00 | 136,100.0000 | 51,200,000 | 14.69% | 0.03% |
| May 23, 2024 | DeGolyer Donald W | Director | A | Stock Option (Right to Buy) | 25748 | $0.00 | 25,748.0000 | 51,200,000 | 9999.99% | 0.05% |
| May 23, 2024 | White Marvin L | Director | A | Common Stock | 17430 | $0.00 | 68,379.0000 | 51,200,000 | 34.21% | 0.03% |
| May 23, 2024 | White Marvin L | Director | A | Stock Option (Right to Buy) | 25748 | $0.00 | 25,748.0000 | 51,200,000 | 9999.99% | 0.05% |
| May 23, 2024 | Dayal Sujata Tyagi | Director | A | Common Stock | 17430 | $0.00 | 63,129.0000 | 51,200,000 | 38.14% | 0.03% |
| May 23, 2024 | Dayal Sujata Tyagi | Director | A | Stock Option (Right to Buy) | 25748 | $0.00 | 25,748.0000 | 51,200,000 | 9999.99% | 0.05% |
| May 23, 2024 | SULLIVAN LOUIS W | Director | A | Common Stock | 17430 | $0.00 | 104,695.0000 | 51,200,000 | 19.97% | 0.03% |
| May 23, 2024 | SULLIVAN LOUIS W | Director | A | Stock Option (Right to Buy) | 25748 | $0.00 | 25,748.0000 | 51,200,000 | 9999.99% | 0.05% |
| May 23, 2024 | Harsanyi Zsolt | Chairman | A | Common Stock | 17430 | $0.00 | 89,329.0000 | 51,200,000 | 24.24% | 0.03% |
| May 23, 2024 | Harsanyi Zsolt | Chairman | A | Stock Option (Right to Buy) | 25748 | $0.00 | 25,748.0000 | 51,200,000 | 9999.99% | 0.05% |
| May 23, 2024 | Zoon Kathryn C | Director | A | Common Stock | 17430 | $0.00 | 66,312.0000 | 51,200,000 | 35.66% | 0.03% |
| May 23, 2024 | Richard Ronald | Director | A | Common Stock | 17430 | $0.00 | 71,114.0000 | 51,200,000 | 32.47% | 0.03% |
| May 23, 2024 | Richard Ronald | Director | A | Stock Option (Right to Buy) | 25748 | $0.00 | 25,748.0000 | 51,200,000 | 9999.99% | 0.05% |
| May 21, 2024 | Zoon Kathryn C | Director | S | Common Stock | 1089 | $5.78 | 48,882.0000 | 51,200,000 | 2.18% | 0.00% |
| April 7, 2024 | Hartzel William | SVP, Bioservices | F | Common Stock | 665 | $2.29 | 34,274.0000 | 51,200,000 | 1.90% | 0.00% |
| April 7, 2024 | Glessner Coleen | EVP, Quality & Ethics, and CPL | F | Common Stock | 585 | $2.29 | 164,383.0000 | 51,200,000 | 0.35% | 0.00% |
| March 13, 2024 | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | A | Employee Stock Options (Right to Buy) | 125000 | $0.00 | 223,169.0000 | 51,200,000 | 127.33% | 0.24% |
| March 13, 2024 | PAPA JOSEPH C | President and CEO | A | Employee Stock Options (Right to Buy) | 750000 | $0.00 | 750,000.0000 | 51,200,000 | 9999.99% | 1.46% |
| March 13, 2024 | Williams Paul Anthony | SVP, Products Business | A | Employee Stock Options (Right to Buy) | 125000 | $0.00 | 147,614.0000 | 51,200,000 | 552.75% | 0.24% |
| March 13, 2024 | Glessner Coleen | EVP, Quality & Ethics, and CPL | A | Employee Stock Options (Right to Buy) | 125000 | $0.00 | 187,113.0000 | 51,200,000 | 201.25% | 0.24% |
| March 13, 2024 | Hartzel William | SVP, Bioservices | A | Employee Stock Options (Right to Buy) | 125000 | $0.00 | 152,211.0000 | 51,200,000 | 459.37% | 0.24% |
| March 13, 2024 | LINDAHL RICHARD S | EVP, Chief Financial Officer | A | Employee Stock Options (Right to Buy) | 125000 | $0.00 | 305,944.0000 | 51,200,000 | 69.08% | 0.24% |
| March 5, 2024 | Hartzel William | SVP, Bioservices | F | Common Stock | 346 | $3.41 | 34,939.0000 | 51,200,000 | 0.98% | 0.00% |
| March 1, 2024 | Glessner Coleen | EVP, Quality & Ethics, and CPL | F | Common Stock | 381 | $3.39 | 164,968.0000 | 51,200,000 | 0.23% | 0.00% |
| March 1, 2024 | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | F | Common Stock | 703 | $3.39 | 173,758.0000 | 51,200,000 | 0.40% | 0.00% |
| Feb. 29, 2024 | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | F | Common Stock | 4103 | $3.23 | 174,461.0000 | 51,200,000 | 2.30% | 0.01% |
| March 1, 2024 | LINDAHL RICHARD S | EVP, Chief Financial Officer | F | Common Stock | 684 | $3.39 | 158,742.0000 | 51,200,000 | 0.43% | 0.00% |
| Feb. 29, 2024 | LINDAHL RICHARD S | EVP, Chief Financial Officer | F | Common Stock | 9037 | $3.23 | 159,426.0000 | 51,200,000 | 5.36% | 0.02% |
| March 1, 2024 | Williams Paul Anthony | SVP, Products Business | F | Common Stock | 137 | $3.39 | 24,882.0000 | 51,200,000 | 0.55% | 0.00% |
| Feb. 29, 2024 | Williams Paul Anthony | SVP, Products Business | F | Common Stock | 450 | $3.23 | 25,019.0000 | 51,200,000 | 1.77% | 0.00% |
| Feb. 23, 2024 | LINDAHL RICHARD S | EVP, Chief Financial Officer | F | Common Stock | 517 | $2.74 | 168,463.0000 | 51,200,000 | 0.31% | 0.00% |
| Feb. 23, 2024 | Williams Paul Anthony | SVP, Products Business | F | Common Stock | 105 | $2.74 | 25,469.0000 | 51,200,000 | 0.41% | 0.00% |
| Feb. 23, 2024 | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | F | Common Stock | 229 | $2.74 | 178,564.0000 | 51,200,000 | 0.13% | 0.00% |
| Feb. 21, 2024 | LINDAHL RICHARD S | EVP, Chief Financial Officer | D | Common Stock | 4012 | $2.71 | 168,980.0000 | 51,200,000 | 2.32% | 0.01% |